Christian Vestergaard

9.9k total citations
155 papers, 4.2k citations indexed

About

Christian Vestergaard is a scholar working on Dermatology, Immunology and Allergy and Rheumatology. According to data from OpenAlex, Christian Vestergaard has authored 155 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Dermatology, 65 papers in Immunology and Allergy and 44 papers in Rheumatology. Recurrent topics in Christian Vestergaard's work include Dermatology and Skin Diseases (98 papers), Allergic Rhinitis and Sensitization (49 papers) and Urticaria and Related Conditions (43 papers). Christian Vestergaard is often cited by papers focused on Dermatology and Skin Diseases (98 papers), Allergic Rhinitis and Sensitization (49 papers) and Urticaria and Related Conditions (43 papers). Christian Vestergaard collaborates with scholars based in Denmark, Germany and United States. Christian Vestergaard's co-authors include Mette Deleuran, Kouji Matsushima, Hiroyuki Yoneyama, Christian Grønhøj, Borbala Gesser, Malene Hvid, Uffe Nygaard, Claus Johansen, Bent Deleuran and Masako Murai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Christian Vestergaard

140 papers receiving 4.1k citations

Peers

Christian Vestergaard
Christian Vestergaard
Citations per year, relative to Christian Vestergaard Christian Vestergaard (= 1×) peers Mette Deleuran

Countries citing papers authored by Christian Vestergaard

Since Specialization
Citations

This map shows the geographic impact of Christian Vestergaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christian Vestergaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christian Vestergaard more than expected).

Fields of papers citing papers by Christian Vestergaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christian Vestergaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christian Vestergaard. The network helps show where Christian Vestergaard may publish in the future.

Co-authorship network of co-authors of Christian Vestergaard

This figure shows the co-authorship network connecting the top 25 collaborators of Christian Vestergaard. A scholar is included among the top collaborators of Christian Vestergaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christian Vestergaard. Christian Vestergaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deleuran, Mette, et al.. (2025). Setting Patient-Centered Treatment Goals in Atopic Dermatitis: Shared Decision and A Treat-to-target Strategy. Current Treatment Options in Allergy. 12(1). 1 indexed citations
2.
Bruin‐Weller, Marjolein de, Celeste M. Boesjes, Lisa A. Beck, et al.. (2025). Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions. Allergy. 81(2). 326–344. 1 indexed citations
3.
Sørensen, Jennifer Astrup, Zarqa Ali, Christian Vestergaard, et al.. (2025). EXtending Omalizumab Treatment Intervals in patients with Chronic spontaneous urticaria (EXOTIC): protocol of a multicentre, randomised, open-label, non-inferiority trial. BMJ Open. 15(1). e084987–e084987. 1 indexed citations
4.
Chan, K.T., Hsuan‐Chi Chen, Paul Allen, et al.. (2025). Atopic dermatitis epidemiological research methodology: a global scoping review. British Journal of Dermatology. 193(5). 830–838.
5.
Schmidt, Sigrún Alba Jóhannesdóttir, Dóra Körmendiné Farkas, Mette Deleuran, et al.. (2025). Long‐term socioeconomic outcomes in Danish children with moderate‐to‐severe atopic dermatitis. Journal of the European Academy of Dermatology and Venereology. 40(1). 79–89.
6.
Sørensen, Jennifer Astrup, Christian Vestergaard, Emek Kocatürk, et al.. (2025). Omalizumab dosing patterns and drug survival in adult patients with chronic spontaneous urticaria. Journal of the European Academy of Dermatology and Venereology. 39(10). 1796–1805. 1 indexed citations
7.
Farkas, Dóra Körmendiné, Christian Vestergaard, Sigrún Alba Jóhannesdóttir Schmidt, et al.. (2024). Urticaria and the risk of cancer: a Danish population-based cohort study. British Journal of Dermatology. 191(5). 706–712. 1 indexed citations
8.
Türk, Murat, Emek Kocatürk, Ragıp Ertaş, et al.. (2024). A global perspective on stepping down chronic spontaneous urticaria treatment: Results of the Urticaria Centers of Reference and Excellence SDown‐CSU study. Clinical and Translational Allergy. 14(2). 5 indexed citations
9.
Renert‐Yuval, Yael, Ester Del Duca, B.W.M. Arents, et al.. (2023). Treat‐to‐target in dermatology: A scoping review and International Eczema Council survey on the approach in atopic dermatitis. Journal of the European Academy of Dermatology and Venereology. 38(1). 42–51. 7 indexed citations
10.
Vittrup, Ida, Niels Steen Krogh, Jesper Elberling, et al.. (2023). A nationwide 104 weeks real‐world study of dupilumab in adults with atopic dermatitis: Ineffectiveness in head‐and‐neck dermatitis. Journal of the European Academy of Dermatology and Venereology. 37(5). 1046–1055. 32 indexed citations
11.
Graaf, Marlies de, Sherief R. Janmohamed, Marie L. A. Schuttelaar, et al.. (2022). Systemic treatment of children and adolescents with atopic dermatitis aged ≥2 years: a Delphi consensus project mapping expert opinion in Northern Europe. Journal of the European Academy of Dermatology and Venereology. 36(11). 2153–2165. 12 indexed citations
12.
Vestergaard, Christian, et al.. (2021). Eleven Danish patients diagnosed with Scabies and treated with Tenutex®. SHILAP Revista de lepidopterología. 9(3). 1688–1690. 5 indexed citations
13.
Luger, Thomas A., Matthias Augustin, Julien Lambert, et al.. (2020). Unmet medical needs in the treatment of atopic dermatitis in infants: An Expert consensus on safety and efficacy of pimecrolimus. Pediatric Allergy and Immunology. 32(3). 414–424. 9 indexed citations
14.
Gerner, Trine, Christian Vestergaard, Mette Deleuran, et al.. (2020). Healthcare utilization in Danish children with atopic dermatitis and parental topical corticosteroid phobia. Pediatric Allergy and Immunology. 32(2). 331–341. 15 indexed citations
15.
Rønholt, Kirsten, Claus Johansen, Christian Vestergaard, et al.. (2020). IL-37 Expression Is Downregulated in Lesional Psoriasis Skin. ImmunoHorizons. 4(11). 754–761. 24 indexed citations
16.
Alexander, Helen, Amy S. Paller, Claudia Traidl‐Hoffmann, et al.. (2019). The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group. British Journal of Dermatology. 182(6). 1331–1342. 123 indexed citations
17.
Gerbens, Louise A. A., Angela L. Bosma, Christian Apfelbacher, et al.. (2019). TRE atment of AT opic eczema ( TREAT ) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registries. British Journal of Dermatology. 181(3). 492–504. 21 indexed citations
18.
Nygaard, Uffe, et al.. (2016). Increased IL-25 levels in the peritoneal fluid of patients with endometriosis. Journal of Reproductive Immunology. 114. 6–9. 20 indexed citations
19.
Vestergaard, Christian, et al.. (2014). [Arsenical keratosis treated by dermatome shaving].. PubMed. 176(19).
20.
Deleuran, Mette, et al.. (2012). IL-25 Induces Both Inflammation and Skin Barrier Dysfunction in Atopic Dermatitis. Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy. 96. 45–49. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026